Healthcare provider profile · identity verified

Wamiq Sultan, MD

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology · GARNET VALLEY, PA · NPI 1699873463

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Wamiq Sultan, MD received $134.52 in general payments during 2025 across 8 reported records.

Ardelyx, Inc. accounted for 24.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 6 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rexulti.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 35 claims for Fiasp by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 90 claims for Ozempic by this doctor in 2024.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Rexulti by this doctor in 2024.

Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO as an associated drug or biological on 28 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 13 claims for Austedo by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$134.52

8 reported records · 6 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Ardelyx, Inc.	Unresolved — no canonical attribution shown	$32.32	24.0%	2	2025
Travere Therapeutics, Inc.	Unresolved — no canonical attribution shown	$30.84	22.9%	2	2025
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$21.38	15.9%	1	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$18.01	13.4%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$16.39	12.2%	1	2025
Teva Pharmaceuticals USA, Inc.	Unresolved — no canonical attribution shown	$15.58	11.6%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$117.63	7
Education	$16.89	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
IBSRELA Normalized: ibsrela	Drug	Ardelyx, Inc.	$32.32	2	2025
Source payment records 2025-04-02 · Ardelyx, Inc. · $16.25 · Open Payments source 2025-08-27 · Ardelyx, Inc. · $16.07 · Open Payments source
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$21.38	1	2025
Source payment records 2025-05-28 · Otsuka America Pharmaceutical, Inc. · $21.38 · Open Payments source
KRYSTEXXA Normalized: krystexxa	Biological	Amgen Inc.	$18.01	1	2025
Source payment records 2025-07-24 · Amgen Inc. · $18.01 · Open Payments source
Filspari Normalized: filspari	Drug	Travere Therapeutics, Inc.	$16.89	1	2025
Source payment records 2025-01-08 · Travere Therapeutics, Inc. · $16.89 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$16.39	1	2025
Source payment records 2025-02-04 · Novo Nordisk Inc · $16.39 · Open Payments source
AUSTEDO XR Normalized: austedo xr	Drug	Teva Pharmaceuticals USA, Inc.	$15.58	1	2025
Source payment records 2025-01-29 · Teva Pharmaceuticals USA, Inc. · $15.58 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	90	exact normalized	Medicare Part D
REXULTI rexulti	2025	Rexulti	2024	25 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Fiasp open payments reported associated product	CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936	Fiasp · 2024 Exact normalized brand match · 1 Part D row	35	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	90	13
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708	Rexulti · 2024 Exact normalized brand match · 1 Part D row	25	suppressed by CMS
Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference	2025	AUSTEDO open payments reported associated product	CMS Open Payments — General Payments 28 supporting records · 15 recipient NPIs · example record 1247249192	Austedo · 2024 Exact normalized brand match · 1 Part D row	13	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1015	187
Eliquis	Apixaban	815	101
Furosemide	Furosemide	703	157
Levothyroxine Sodium	Levothyroxine Sodium	582	108
Amlodipine Besylate	Amlodipine Besylate	542	120
Pantoprazole Sodium	Pantoprazole Sodium	468	95
Gabapentin	Gabapentin	461	89
Metoprolol Tartrate	Metoprolol Tartrate	456	93
Tamsulosin Hcl	Tamsulosin Hcl	401	75
Potassium Chloride	Potassium Chloride	390	64
Sertraline Hcl	Sertraline Hcl	353	53
Metformin Hcl	Metformin Hcl	351	60
Trazodone Hcl	Trazodone Hcl	350	64
Metoprolol Succinate	Metoprolol Succinate	344	68
Divalproex Sodium	Divalproex Sodium	343	47
Quetiapine Fumarate	Quetiapine Fumarate	341	53
Lisinopril	Lisinopril	319	65
Omeprazole	Omeprazole	319	61
Losartan Potassium	Losartan Potassium	277	66
Mirtazapine	Mirtazapine	268	53
Carvedilol	Carvedilol	267	64
Clopidogrel	Clopidogrel Bisulfate	241	52
Risperidone	Risperidone	210	28
Escitalopram Oxalate	Escitalopram Oxalate	207	31
Hydralazine Hcl	Hydralazine Hcl	197	41
Xarelto	Rivaroxaban	188	17
Famotidine	Famotidine	183	24
Januvia	Sitagliptin Phosphate	182	16
Olanzapine	Olanzapine	164	21
Duloxetine Hcl	Duloxetine Hcl	161	27
Tramadol Hcl	Tramadol Hcl	153	58
Levetiracetam	Levetiracetam	149	21
Silver Sulfadiazine	Silver Sulfadiazine	147	21
Buspirone Hcl	Buspirone Hcl	143	26
Donepezil Hcl	Donepezil Hcl	141	28
Simvastatin	Simvastatin	119	17
Ondansetron Hcl	Ondansetron Hcl	117	58
Albuterol Sulfate Hfa	Albuterol Sulfate	114	47
Fluticasone Propionate	Fluticasone Propionate	113	28
Prednisone	Prednisone	111	50
Alprazolam	Alprazolam	109	27
Midodrine Hcl	Midodrine Hcl	108	30
Lorazepam	Lorazepam	105	41
Finasteride	Finasteride	103	20
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	100	43
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	97	44
Benztropine Mesylate	Benztropine Mesylate	95	14
Lidocaine	Lidocaine	93	21
Sevelamer Carbonate	Sevelamer Carbonate	93	29
Latanoprost	Latanoprost	90	21
Memantine Hcl	Memantine Hcl	90	13
Ozempic	Semaglutide	90	13
Azithromycin	Azithromycin	89	66
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	89	17
Hydroxyzine Hcl	Hydroxyzine Hcl	86	26
Jardiance	Empagliflozin	86	suppressed
Myrbetriq	Mirabegron	85	suppressed
Clonazepam	Clonazepam	84	16
Spironolactone	Spironolactone	83	20
Lactulose	Lactulose	79	16
Allopurinol	Allopurinol	77	22
Montelukast Sodium	Montelukast Sodium	76	19
Pravastatin Sodium	Pravastatin Sodium	76	23
Atenolol	Atenolol	74	15
Breo Ellipta	Fluticasone/Vilanterol	73	13
Lamotrigine	Lamotrigine	72	11
Glimepiride	Glimepiride	71	15
Levofloxacin	Levofloxacin	70	48
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	70	15
Sodium Chloride	0.9 % Sodium Chloride	68	18
Amiodarone Hcl	Amiodarone Hcl	67	13
Budesonide	Budesonide	66	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	13
Farxiga	Dapagliflozin Propanediol	66	13
Incruse Ellipta	Umeclidinium Bromide	65	13
Metolazone	Metolazone	64	17
Clonidine Hcl	Clonidine Hcl	63	12
Entresto	Sacubitril/Valsartan	63	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	63	12
Nifedipine Er	Nifedipine	62	12
Hydrochlorothiazide	Hydrochlorothiazide	61	14
Divalproex Sodium Er	Divalproex Sodium	60	suppressed
Ammonium Lactate	Ammonium Lactate	59	37
Rosuvastatin Calcium	Rosuvastatin Calcium	58	15
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	57	27
Humalog	Insulin Lispro	56	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	54	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	54	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	53	40
Oxybutynin Chloride Er	Oxybutynin Chloride	52	suppressed
Aripiprazole	Aripiprazole	51	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	51	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	20
Bumetanide	Bumetanide	49	15
Fluoxetine Hcl	Fluoxetine Hcl	49	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	suppressed
Cephalexin	Cephalexin	48	32
Citalopram Hbr	Citalopram Hydrobromide	48	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	47	suppressed
Sucralfate	Sucralfate	47	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	45	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	suppressed
Vascepa	Icosapent Ethyl	45	suppressed
Cefuroxime	Cefuroxime Axetil	44	28
Colchicine	Colchicine	44	suppressed
Diclofenac Sodium	Diclofenac Sodium	44	23
Oxycodone Hcl	Oxycodone Hcl	44	18
Pregabalin	Pregabalin	44	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	43	43
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Glipizide	Glipizide	41	11
Xifaxan	Rifaximin	41	suppressed
Alendronate Sodium	Alendronate Sodium	40	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	39	14
Valproic Acid	Valproic Acid (As Sodium Salt)	39	suppressed
Haloperidol	Haloperidol	38	suppressed
Meloxicam	Meloxicam	38	suppressed
Vancomycin Hcl	Vancomycin Hcl	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	27
Enoxaparin Sodium	Enoxaparin Sodium	35	suppressed
Fiasp	Insulin Aspart (Niacinamide)	35	suppressed
Santyl	Collagenase Clostridium Hist.	35	21
Bupropion Hcl Sr	Bupropion Hcl	34	suppressed
Mupirocin	Mupirocin	34	23
Oxycontin	Oxycodone Hcl	34	suppressed
Albuterol Sulfate	Albuterol Sulfate	33	11
Cholestyramine	Cholestyramine (With Sugar)	33	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Methylprednisolone	Methylprednisolone	33	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	27
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	20
Brimonidine Tartrate	Brimonidine Tartrate	31	suppressed
Calcium Acetate	Calcium Acetate	31	12
Procrit	Epoetin Alfa	31	suppressed
Valsartan	Valsartan	31	suppressed
Velphoro	Sucroferric Oxyhydroxide	31	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	30	suppressed
Baclofen	Baclofen	30	suppressed
Brilinta	Ticagrelor	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	30	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	30	suppressed
Labetalol Hcl	Labetalol Hcl	29	suppressed
Nystatin	Nystatin	29	19
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Ramipril	Ramipril	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Linzess	Linaclotide	27	suppressed
Novolog	Insulin Aspart	27	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	27	11
Valacyclovir	Valacyclovir Hcl	27	suppressed
Fluconazole	Fluconazole	26	24
Insulin Lispro	Insulin Lispro	26	16
Invokana	Canagliflozin	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Calcitriol	Calcitriol	25	suppressed
Dexlansoprazole Dr	Dexlansoprazole	25	suppressed
Nyamyc	Nystatin	25	17
Primidone	Primidone	25	suppressed
Rexulti	Brexpiprazole	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	13
Arformoterol Tartrate	Arformoterol Tartrate	24	suppressed
Auryxia	Ferric Citrate	24	suppressed
Digoxin	Digoxin	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Dexamethasone	Dexamethasone	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Lacosamide	Lacosamide	22	suppressed
Prednisolone Acetate	Prednisolone Acetate	22	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	21	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	21	suppressed
Cefdinir	Cefdinir	20	17
Ibuprofen	Ibuprofen	20	suppressed
Meropenem	Meropenem	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Zonisade	Zonisamide	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Torsemide	Torsemide	19	suppressed
Amoxicillin	Amoxicillin	18	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Ondansetron Odt	Ondansetron	18	14
Topiramate	Topiramate	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Nystop	Nystatin	17	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	17	12
Timolol Maleate	Timolol Maleate	17	suppressed
Acetic Acid	Acetic Acid	16	suppressed
Dilt-Xr	Diltiazem Hcl	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Rivastigmine	Rivastigmine Tartrate	16	suppressed
Sevelamer Hcl	Sevelamer Hcl	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Veltassa	Patiromer Calcium Sorbitex	16	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	12
Colestipol Hcl	Colestipol Hcl	15	suppressed
Diazepam	Diazepam	15	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Hydromorphone Er	Hydromorphone Hcl	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Valproic Acid	Valproic Acid	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Febuxostat	Febuxostat	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Naproxen	Naproxen	14	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Austedo	Deutetrabenazine	13	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	13	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Metaxalone	Metaxalone	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Aripiprazole Odt	Aripiprazole	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Avonex (4 Pack)	Interferon Beta-1a	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Fetzima	Levomilnacipran Hcl	11	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Propafenone Hcl Er	Propafenone Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Ursodiol	Ursodiol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$134.52 · 8 records	Ardelyx, Inc.	AUSTEDO XR, Filspari, IBSRELA, KRYSTEXXA, Ozempic, REXULTI	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error